Skip to main content
. 2022 Jun 16;14(12):2971. doi: 10.3390/cancers14122971

Figure 4.

Figure 4

TP53 status in EGFR mutated cases in early- and advanced-stage tumors. Bar graphs show the percentage of EGFR-mutated samples with either wild-type or mutated TP53 genotype.